Peter Kuhn

Innovative Molecular Analysis Technologies, part of the National Cancer Institute’s Center for Strategic Initiatives, features CSI-Cancer’s High-Definition Single Cell Analysis (HD-SCA) workflow as a top success story among impactful technologies in the field of single cell oncology. (November 5, 2019)